Euclidean Capital LLC

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Euclidean Capital LLC reported 11 stock positions worth $906.8 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 76.1% of the portfolio, followed by iShares MSCI India ETF (INDA, 15.7%) and Vanguard Ftse All-World Ex-U (VEU, 3.5%). Compared with Q2 2024, it opened 1 new position and added to 1. The biggest buy was a new position in Vanguard Ftse All-World Ex-U (VEU).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001825034
Portfolio Value
$906.8M (Q3 2024)
SEC Filing
0001012975-24-000483 ↗ filed Nov 14, 2024

Holdings Value

0$200.0M$400.0M$600.0M$800.0M$1.0B Q1 2024: $780.0M Q1 2024 Q2 2024: $795.8M Q2 2024 Q3 2024: $906.8M $906.8M Q3 2024 Q4 2024: $736.7M Q4 2024 Q1 2025: $266.1M Q1 2025 Q2 2025: $305.7M Q2 2025 Q3 2025: $238.0M Q3 2025 Q4 2025: $369.4M Q4 2025 Q1 2026: $392.3M Q1 2026 Q2 2026: $439.8M Q2 2026

Holdings 11 stocks · $906.8M
SPY SS SPDR S&P 500 ETF Trust-US 76.11% 1,202,804 $690.1M Add +4.9%
INDA iShares MSCI India ETF 15.65% 2,425,144 $141.9M No change
VEU Vanguard Ftse All-World Ex-U 3.53% 507,600 $32.0M New
FHTX Foghorn Therapeutics Inc. 1.62% 1,573,761 $14.7M No change
ORIC Oric Pharmaceuticals Inc. 1.12% 989,410 $10.1M No change
ALEC Alector Inc. 0.67% 1,307,858 $6.1M No change
PMVP PMV Pharmaceuticals Inc. 0.43% 2,627,643 $3.9M No change
23ANDME HOLDING CO 0.40% 10,243,122 $3.6M No change
TNYA Tenaya Therapeutics Inc. 0.22% 1,015,705 $2.0M No change
RAPT THERAPEUTICS INC 0.15% 657,899 $1.3M No change
SRZN Surrozen Inc. 0.12% 87,696 $1.1M No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $2K (not counted above)
SecurityClassShares / PrincipalValueChange
SRZNW Surrozen Inc.-CW25 *W EXP 08/01/203 170,833$2KNo change

Total filed on the 13F, all lines: $906.8M.

Portfolio Sells Q2 2024 → Q3 2024
None this quarter.

Portfolio Buys Q2 2024 → Q3 2024
VEU Vanguard Ftse All-World Ex-U New 3.53% +3.53
SPY SS SPDR S&P 500 ETF Trust-US Add +4.9% 76.11% −2.33

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 10$439.8MVEU, VTV, INDA, ORIC, TMS
Q1 2026 9$392.3MVEU, VTV, INDA, ORIC, FHTX
Q4 2025 11$369.4MVEU, VTV, INDA, FHTX, ORIC
Q3 2025 10$238.0MVEU, INDA, ORIC, FHTX, ALEC
Q2 2025 10$305.7MVEU, INDA, ORIC, FHTX, PMVP
Q1 2025 10$266.1MINDA, VEU, FHTX, ORIC, PMVP
Q4 2024 10$736.7MSPY, INDA, VEU, ORIC, FHTX
Q3 2024 11$906.8MSPY, INDA, VEU, FHTX, ORIC
Q2 2024 10$795.8MSPY, INDA, FHTX, ORIC, ALEC
Q1 2024 12$780.0MSPY, INDA, GLD, ORIC, FHTX